Ambrx Biopharma OverviewAmbrx Biopharma Net Income
Profitability analysis for AMAM.
Quarterly Net Income
-$22.99M
↓ 73.46% YoY
As of Sep 2023
Annual Net Income (TTM)
-$69.37M
↑ 19.28% YoY
Trailing 12 months ending Sep 2023
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...